Can Neuron Specific Enolase Be a Diagnostic Biomarker for Neuronal Injury in COVID-19?

Latha Ganti; Enrique Serrano; Hale Z Toklu

doi:10.7759/CUREUS.11033

Can Neuron Specific Enolase Be a Diagnostic Biomarker for Neuronal Injury in COVID-19?

Latha Ganti
, Enrique Serrano
, Hale Z Toklu

University of Central Florida

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Cureus
Volume	12
Issue number	10
DOIs	https://doi.org/10.7759/CUREUS.11033
State	Published - Oct 19 2020
Externally published	Yes

Disciplines

Medicine and Health Sciences
Pathology

Access to Document

10.7759/CUREUS.11033License: Unspecified

Cite this

@article{a07eadc3d9dc438aa203544aeab55019,

title = "Can Neuron Specific Enolase Be a Diagnostic Biomarker for Neuronal Injury in COVID-19?",

author = "Latha Ganti and Enrique Serrano and Toklu, \{Hale Z\}",

note = "Neuron specific enolase (NSE) is a biomarker for neuronal injury. However, increased levels in cerebrospinal fluid (CSF) and serum is associated with the clinical outcome in patients with head injury, ischemic stroke, intracerebral hemorrhage, cardiac arrest, anoxic encephalopathy, encephalitis, brain metastasis, and status epilepticus.",

year = "2020",

month = oct,

day = "19",

doi = "10.7759/CUREUS.11033",

language = "American English",

volume = "12",

journal = "Cureus",